A phase I study of ampligen in human immunodeficiency virus-infected subjects.
Armstrong JA, McMahon D, Huang XL, Pazin GJ, Gupta P, Rinaldo CR Jr, Schoenfeld DA, Gaccione P, Tripoli CA, Bensasi S, et al.
Armstrong JA, et al.
J Infect Dis. 1992 Oct;166(4):717-22. doi: 10.1093/infdis/166.4.717.
J Infect Dis. 1992.
PMID: 1527407
Clinical Trial.